Sign in
4

Changes in Ownership

HCW Biologics Inc. Filed Acc 0001209191-23-053344

Chief Financial Officer acquired 47,249 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Byam Rebecca Chief Financial Officer 2023-10-19 Option exercise +47,249 $0.14 $6,615 621,195 D
Derivatives
Byam Rebecca Chief Financial Officer 2023-10-19 Option exercise · Stock Option Grant (Right to Buy) −47,249 0 D
Loading xslF345X05/doc4.xml…